• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病预防控制中心“高危”供者与肾脏利用。

Centers for Disease Control 'high-risk' donors and kidney utilization.

机构信息

Department of Anesthesiology, University of Michigan Health System, Ann Arbor, MI, USA.

出版信息

Am J Transplant. 2010 Feb;10(2):416-20. doi: 10.1111/j.1600-6143.2009.02931.x. Epub 2009 Dec 2.

DOI:10.1111/j.1600-6143.2009.02931.x
PMID:19958324
Abstract

The aims of this study were to determine whether Centers for Disease Control high risk (CDCHR) status of organ donors affects kidney utilization and recipient survival. Data from the Scientific Registry of Transplant Recipients were used to examine utilization rates of 45,112 standard criteria donor (SCD) deceased donor kidneys from January 1, 2005, and February 2, 2009. Utilization rates for transplantation were compared between CDCHR and non-CDCHR kidneys, using logistic regression to control for possible confounders. Cox regression was used to determine whether CDCHR status independently affected posttransplant survival among 25,158 recipients of SCD deceased donor kidneys between January 1, 2005, and February 1, 2008. CDCHR kidneys were 8.2% (95% CI 6.9-9.5) less likely to be used for transplantation than non-CDCHR kidneys; after adjusting for other factors, CDCHR was associated with an odds ratio of utilization of 0.67 (95% CI 0.61-0.74). After a median 2 years follow-up, recipients of CDCHR kidneys had similar posttransplant survival compared to recipients of non-CDCHR kidneys (hazard ratio 1.06, 95% CI 0.89-1.26). These findings suggest that labeling donor organs as 'high risk' may result in wastage of approximately 41 otherwise standard kidneys per year.

摘要

本研究旨在确定器官捐献者的疾病控制中心高危(CDCHR)状态是否影响肾脏的利用和受者的生存。利用移植受者科学注册处的数据,检查了 2005 年 1 月 1 日至 2009 年 2 月 2 日期间 45112 例标准标准供体(SCD)已故供体肾脏的利用率。使用逻辑回归控制可能的混杂因素,比较 CDCHR 和非 CDCHR 肾脏的移植利用率。使用 Cox 回归确定 CDCHR 状态是否独立影响 2005 年 1 月 1 日至 2008 年 2 月 1 日期间 25158 例 SCD 已故供体肾脏受者的移植后生存。CDCHR 肾脏用于移植的可能性比非 CDCHR 肾脏低 8.2%(95%CI 6.9-9.5);在调整其他因素后,CDCHR 与利用率的比值比为 0.67(95%CI 0.61-0.74)相关。中位随访 2 年后,CDCHR 肾脏受者与非 CDCHR 肾脏受者的移植后生存相似(风险比 1.06,95%CI 0.89-1.26)。这些发现表明,将供体器官标记为“高危”可能导致每年浪费约 41 个标准肾脏。

相似文献

1
Centers for Disease Control 'high-risk' donors and kidney utilization.疾病预防控制中心“高危”供者与肾脏利用。
Am J Transplant. 2010 Feb;10(2):416-20. doi: 10.1111/j.1600-6143.2009.02931.x. Epub 2009 Dec 2.
2
Outcomes of renal transplants from Centers for Disease Control and Prevention high-risk donors with prospective recipient viral testing: a single-center experience.疾病控制与预防中心高风险供体肾移植并对接受者进行前瞻性病毒检测的结果:单中心经验
Arch Surg. 2011 Nov;146(11):1261-6. doi: 10.1001/archsurg.2011.267.
3
Association of Deceased Donor Acute Kidney Injury With Recipient Graft Survival.死亡供体急性肾损伤与受者移植物存活的关系。
JAMA Netw Open. 2020 Jan 3;3(1):e1918634. doi: 10.1001/jamanetworkopen.2019.18634.
4
Explainable variation in renal transplant outcomes: a comparison of standard and expanded criteria donors.肾移植结果的可解释变异:标准和扩大标准供体的比较。
Clin Transpl. 2004:303-14.
5
The weekend effect alters the procurement and discard rates of deceased donor kidneys in the United States.周末效应改变了美国已故捐赠者肾脏的获取和丢弃率。
Kidney Int. 2016 Jul;90(1):157-63. doi: 10.1016/j.kint.2016.03.007. Epub 2016 May 12.
6
The OPTN/UNOS Renal Transplant Registry.器官获取与移植网络/美国器官共享联合网络肾脏移植登记处
Clin Transpl. 2005:1-16.
7
Young deceased donor kidneys show a survival benefit over older donor kidneys in transplant recipients aged 20-50 years: a study by the ERA-EDTA Registry.年轻的已故供体肾脏在 20-50 岁的移植受者中比年龄较大的供体肾脏具有生存优势:来自 ERA-EDTA 登记处的一项研究。
Nephrol Dial Transplant. 2020 Mar 1;35(3):534-543. doi: 10.1093/ndt/gfy268.
8
The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: a registry analysis.活体供肾、标准及扩大标准死体供肾肾移植受者的癌症风险:一项登记分析
Transplantation. 2014 Dec 27;98(12):1286-93. doi: 10.1097/TP.0000000000000375.
9
Epidemiology of Kidney Discard from Expanded Criteria Donors Undergoing Donation after Circulatory Death.循环死亡后进行捐献的扩大标准供体肾脏弃用的流行病学
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):317-23. doi: 10.2215/CJN.07190715. Epub 2015 Dec 14.
10
Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.直接作用抗病毒治疗时代 HCV 抗体阳性的已故供肾的使用和废弃的变化。
Transplantation. 2018 Dec;102(12):2088-2095. doi: 10.1097/TP.0000000000002323.

引用本文的文献

1
Sexual and gender minoritized persons in organ and tissue donation: a qualitative analysis.器官和组织捐赠中的性少数群体和性别少数群体:一项定性分析。
Can J Anaesth. 2025 Jul 15. doi: 10.1007/s12630-025-03011-4.
2
Exploring the attitudes of solid organ transplant recipients towards COVID-19 shielding communications and the language of 'clinically extremely vulnerable': a qualitative study investigating lessons for the future.探索实体器官移植受者对新冠病毒防护沟通及“临床极度脆弱”表述的态度:一项关于未来经验教训的定性研究
BMJ Public Health. 2024 Mar 19;2(1):e000695. doi: 10.1136/bmjph-2023-000695. eCollection 2024 Jun.
3
Increased Infectious Risk Donor Status and Equity-Relevant Predictors of Organ Donation Organization Approach and Caregiver Consent for Deceased Organ Donation in a Canadian Province (2015-2021).
加拿大某省(2015 - 2021年)器官捐赠组织方法及死者器官捐赠照料者同意书的感染风险增加捐赠者状态与公平相关预测因素
Clin Transplant. 2024 Dec;38(12):e70058. doi: 10.1111/ctr.70058.
4
Organ Nonutilization Following Revision to the Public Health Service Donor Risk Criteria for HIV, HCV, or HBV Transmission.修订公共卫生服务机构关于人类免疫缺陷病毒(HIV)、丙型肝炎病毒(HCV)或乙型肝炎病毒(HBV)传播的捐赠者风险标准后器官未被利用的情况。
Transplantation. 2024 Jun 1;108(6):1440-1447. doi: 10.1097/TP.0000000000004929. Epub 2024 Feb 16.
5
Observational Study Examining Kidney Transplantation Outcomes Following Donation From Individuals That Died of Drug Toxicity in British Columbia, Canada.一项观察性研究:考察加拿大不列颠哥伦比亚省死于药物毒性个体捐赠后的肾移植结果。
Can J Kidney Health Dis. 2023 Apr 4;10:20543581231156853. doi: 10.1177/20543581231156853. eCollection 2023.
6
Impact of deceased organ donor injection drug use on donor culture positivity and recipient outcomes.器官捐献者生前使用注射毒品对供体培养物阳性和受者结局的影响。
Transpl Infect Dis. 2022 Dec;24(6):e13942. doi: 10.1111/tid.13942. Epub 2022 Aug 30.
7
Consent to organ offers from public health service "Increased Risk" donors decreases time to transplant and waitlist mortality.同意从公共卫生服务机构的“高风险”供体中获取器官,可以缩短移植和等待名单上的死亡率所需的时间。
BMC Med Ethics. 2022 Mar 5;23(1):20. doi: 10.1186/s12910-022-00757-0.
8
Donor management using a specialized donor care facility is associated with higher organ utilization from drug overdose donors.使用专门的供体护理机构进行供体管理与药物过量供体的器官利用率较高有关。
Clin Transplant. 2021 Mar;35(3):e14178. doi: 10.1111/ctr.14178. Epub 2020 Dec 14.
9
Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.评估实体器官捐献者和监测人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒感染的移植受者-美国卫生与公众服务部 2020 年指南。
MMWR Recomm Rep. 2020 Jun 26;69(4):1-16. doi: 10.15585/mmwr.rr6904a1.
10
Kidney nonprocurement in solid organ donors in the United States.美国实体器官捐献者的肾脏未被获取情况。
Am J Transplant. 2020 Dec;20(12):3413-3425. doi: 10.1111/ajt.15952. Epub 2020 May 16.